Abstract
Sexual dysfunction in women is defined as disorders of sexual desire, arousal, orgasm, and/or sexual pain, which result in significant personal distress and may have a negative effect on a woman’s health and an impact on the quality of life. A comprehensive understanding of the anatomical, neurobiological, and psychological mechanisms behind women’s sexual function and dysfunction is of paramount importance. We sought to review the most frequent clinical pathophysiological mechanisms of women’s desire, arousal, and orgasmic dysfunctions. Likewise, we tried to consider the different disorders from the point of view of the daily clinical practice, trying to give an updated vision of lines of therapy currently being studied or of clear application, especially considering the disorders of sexual desire and arousal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal A, Deepinder F, Cocuzza M et al (2008) Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study. Fertil Steril 89:375–379
Alexander MS, Rosen RC, Steinberg S et al (2011) Sildenafil in women with sexual arousal disorder following spinal cord injury. Spinal Cord 49:273–279
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edn. text revision ed. American Psychiatric Association, Washington, DC
Angst J (1998) Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 13(suppl 6):S1–S4
Archer DF (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17:194–203
Argiolas A, Melis MR (2003) The neurophysiology of the sexual cycle. J Endocrinol Invest 26(Suppl 3):20–22
Bachmann G (2006) Female sexuality and sexual dysfunction: are we stuck on the learning curve? J Sex Med 3:639–645
Bachmann G, Lobo RA, Gut R et al (2008) Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 111:67–76
Basson R (2000) The female sexual response: a different model. J Sex Marital Ther 26:51–65
Basson R (2001) Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 998:350–353
Basson R (2002a) The complexities of female sexual arousal disorder: potential role of pharmacotherapy. World J Urol 20:119–126
Basson R (2002b) A model of woman’s sexual arousal. J Sex Marital Ther 28:1–10
Basson R (2009) Pharmacotherapy for women’s sexual dysfunction. Expert Opin Pharmacother 10:1631–1648
Basson R, Brotto LA (2003) Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomized controlled trial. BJOG 110:1014–1124
Basson R, Berman J, Burnett A et al (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163:888–893
Basson R, Leiblum S, Brotto L et al (2003) Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 24:221–229
Basson R, Leiblum S, Brotto L et al (2004) Revised definitions of women’s sexual dysfunction. J Sex Med 1:40–48
Basson R, Rees P, Wang R et al (2010) Sexual function in chronic illness. J Sex Med 7:374–388
Binik YM (2010) The DSM diagnostic criteria for vaginismus. Arch Sex Behav 39:278–291
Bitzer J, Giraldi A, Pfaus J (2013a) Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1). J Sex Med 10:36–49
Bitzer J, Giraldi A, Pfaus J (2013b) A standardized diagnostic interview for hypoactive sexual desire disorder in women: standard operating procedure (SOP Part 2). J Sex Med 10:50–57
Blaicher W, Gruber D, Bieglmayer C et al (1999) The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest 47:125–126
Bloemers J, van Rooij K, Poels S et al (2013) Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for Hypoactive Sexual Desire Disorder and female sexual arousal disorder. J Sex Med 10:791–809
Bornstein J, Maman M, Abramovici H (2001) “Primary” vs “secondary” vulvar vestibulitis: one disease, two variants. Am J Obstet Gynecol 184:28–31
Brin MF, Vapnek JM (1997) Treatment of vaginismus with botulinum toxin injections. Lancet 349:252–253
Brotto LA, Krychman M, Jacobson P (2008) Eastern approaches for enhancing women’s sexuality: mindfulness, acupuncture, and yoga (CME). J Sex Med 5:2741–2748
Brotto LA, Bitzer J, Laan E et al (2010) Women’s sexual desire and arousal disorders. J Sex Med 7(1 Pt 2):586–614
Brotto LA, Petkau AJ, Labrie F et al (2011) Predictors of sexual desire disorders in women. J Sex Med 8:742–753
Burri A, Spector T (2011) Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. J Sex Med 8:2420–2430
Burri A, Greven C, Leupin M et al (2012) A multivariate twin study of female sexual dysfunction. J Sex Med 9:2671–2681
Burrows LJ, Basha M, Goldstein AT (2012) The effects of hormonal contraceptives on female sexuality: a review. J Sex Med 9:2213–2223
Chivers ML, Rosen RC (2010) Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med 7:858–872
Chudakov B, Ben Zion IZ, Belmaker RH (2007) Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med 4:204–208
Clayton AH (2007) Epidemiology and neurobiology of female sexual dysfunction. J Sex Med 4(Suppl 4):260–268
Clayton AH, Balon R (2009) The impact of mental illness and psychotropic medications on sexual functioning: the evidence and management. J Sex Med 6:1200–1211
Clayton AH, Warnock JK, Kornstein SG et al (2004) A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor induced sexual dysfunction. J Clin Psychiatry 65:62–67
Danielson I, Sjoberg I, Stenlund H et al (2003) Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health 31:113–118
Davis SR, Braunstein GD (2012) Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 9:1134–1148
Davis SR, Guay AT, Shifren JL et al (2004) Endocrine aspects of female sexual dysfunction. J Sex Med 1:82–86
Davis SR, Davison SL, Donath S et al (2005) Circulating androgen levels and self-reported sexual function in women. JAMA 294:91–96
Davis SR, Moreau M, Kroll R et al (2008a) Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359:2005–2017
Davis S, Papalia MA, Norman RJ et al (2008b) Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med 148:569–577
Davis SR, Wolfe R, Farrugia H et al (2009) The incidence of invasive breast cancer among women prescribed testosterone for low libido. J Sex Med 6:1850–1856
Davison SL, Davis SR (2011) Androgenic hormones and aging: the link with female sexual function. Horm Behav 59:745–753
Davison SL, Bell R, Donath S et al (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853
Davison SL, Bell RJ, Lachina M et al (2008) Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med 5:1214–1222
de Kruiff ME, ter Kuile PTM, Weijenborg PTM et al (2000) Vaginismus and dyspareunia: is there a difference in clinical presentation? J Psychosom Obstet Gynecol 21:149–155
Dennerstein L, Burrows GD, Wood C et al (1980) Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 56:316–322
Dennerstein L, Alexander JL, Kotz K (2003) The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res 14:64–82
Dennerstein L, Koochaki P, Barton I et al (2006) Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 3:212–222
Dennerstein L, Lehert P, Guthrie JR, Burger HG (2007) Modeling women’s health during the menopausal transition: a longitudinal analysis. Menopause 14:53–62
Derogatis LR, Komer L, Katz M et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med 9:1074–1085
Dezarnaulds G, Fraser IS (2003) Vaginal ring delivery of hormone replacement therapy–a review. Expert Opin Pharmacother 4:201–212
Dhingra C, Kellogg-Spadt S, McKinney TB et al (2012) Urogynecological causes of pain and the effect of pain on sexual function in women. Female Pelvic Med Reconstr Surg 18:259–267
Dunn KM, Cherkas LF, Spector TD (2005) Genetic influences on variation in female orgasmic function: a twin study. Biol Lett 1:260–263
Engman M, Lindehammar H, Wijma B (2004) Surface electromyography diagnostics in women with partial vaginismus with or without vulvar vestibulitis and in asymptomatic women. J Psychosom Obstet Gynecol 25:281–294
Fabre LF, Brown CS, Smith LC et al (2011) Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. J Sex Med 8:1411–1419
Ferrero S, Ragni N, Remorgida V (2008) Deep dyspareunia: causes, treatments and results. Curr Opin Obstet Gynecol 20:394–399
Frank E, Anderson C, Rubinstein D (1978) Frequency of sexual dysfunction in “normal” couples. N Engl J Med 299:111–115
Friedrich EG Jr (1987) Vulvar vestibulitis syndrome. J Reprod Med 32:110–114
Fugl-Meyer KS, Bohm-Starke N, Damsted Petersen C et al (2013) Standard operating procedures for female genital sexual pain. J Sex Med 10:83–93
Giraldi A, Kristensen E (2010) Sexual dysfunction in women with diabetes mellitus. J Sex Res 47:199–211
Giraldi A, Rellini A, Pfaus JG et al (2011) Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med 8:2681–2706
Giraldi A, Rellini AH, Pfaus J et al (2013) Female sexual arousal disorders. J Sex Med 10:58–73
Giuliano F, Pfaus J, Balasubramanian S et al (2010) Experimental models for the study of female and male sexual function. J Sex Med 7:2970–2995
Goldfischer ER, Breaux J, Katz M et al (2011) Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder(HSDD): results from a randomized withdrawal trial. J Sex Med 8:3160–3172
Goldstat R, Briganti E, Tran J et al (2003) Transdermal testosterone therapy improves well being, mood, and sexual function in premenopausal women. Menopause 10:390–398
Goldstein AT, Burrows L (2008) Vulvodynia. J Sex Med 5:5–14
Goldstein MK, Teng NN (1991) Gynecologic factors in sexual dysfunction of the older women. Clin Geriatr Med 7:41–61
Goldstein I, Graziottin A, Heiman JR et al (1999) First international consultation on erectile dysfunction, Chapter 14, pp 507–556
Graham MD, Pfaus JG (2010) Differential regulation of female sexual behaviour by dopamine agonists in the medial preoptic area. Pharmacol Biochem Behav 97:284–292
Granot M, Friedman M, Yarnitsky D et al (2004) Primary and secondary vulvar vestibulitis syndrome: systemic pain perception and psychophysical characteristics. Am J Obstet Gynecol 191:138–142
Graziottin A (2001) Clinical approach to dyspareunia. J Sex Marital Ther 27:489–501
Haefner H (2007) Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia. J Low Genit Tract Dis 11:48–49
Harlow BL, Stewart EG (2003) A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 58:82–88
Hayes RD, Bennett CM, Fairley CK, Dennerstein L (2006) What can prevalence studies tell us about female sexual difficulty and dysfunction? J Sex Med 3:589–595
Hayes RD, Dennerstein L, Bennett CM et al (2008a) What is the ‘true’ prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 5:777–787
Hayes RD, Dennerstein L, Bennett CM et al (2008b) Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress. J Sex Med 5:1681–1693
Heiman JR (2000) Orgasmic disorders in women. In: Rosen RC, Leiblum SR (eds) Principles and practices of sex therapy. Guilford Press, New York, pp 118–153
Heiman JR, Meston CM (1997) Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 8:148–194
Hickey M, Elliott J, Davison SL (2012) Hormone replacement therapy. BMJ 344:e763
Hite S (2005) The Hite report. New York: Dell; 1976.8 Lloyd EA. The case of the female orgasm: bias in the science of evolution. Harvard University Press, Cambridge, MA
Ishak WW, Bokarius A, Jeffrey JK et al (2010) Disorders of orgasm in women: a literature review of etiology and current treatments. J Sex Med 7:3254–3268
ISSM Health Policy Statement (2011) hypoactive sexual desire disorder in women. J Sex Med 8:1313
Jones LM, McCabe MP (2011) The effectiveness of an Internet-based psychological treatment program for female sexual dysfunction. J Sex Med 8:2781–2792
Kalmbach DA, Ciesla JA, Janata JW et al (2012) Specificity of anhedonic depression and anxious arousal with sexual problems among sexually healthy young adults. J Sex Med 9:505–513
Kaplan H (1974) The new sex therapy. Brunner Mazel, New York
Kelly MP, Strassberg DS, Turner CM (2006) Behavioral assessment of couples’ communication in female orgasmic disorder. J Sex Marital Ther 32:81–95
Kennedy SH, Dickens SE, Eisfeld BS et al (1999) Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 56:201–208
Kim C, Kong S, Laughlin GA et al (2012) Reductions in glucose among postmenopausal women who use and do not use estrogen therapy. Menopause 20(4):393–400
King R, Belsky J, Mah K et al (2011) Are there different types of female orgasm? Arch Sex Behav 40:865–875
Kingsberg SA, Simon JA, Goldstein I (2008) The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 5(Suppl 4):182–193
Kingsberg SA, Tkachenko N, Lucas J et al (2013a) Characterization of orgasmic difficulties by women: focus group evaluation. J Sex Med 10(9):2242–2250. doi:10.1111/jsm.12224
Kingsberg SA, Wysocki S, Magnus L et al (2013b) Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 10(7):1790–1799
Kovalevsky G (2005) Female sexual dysfunction and use of hormone therapy in postmenopausal women. Semin Reprod Med 23:180–187
Krychman ML (2011) Vaginal estrogens for the treatment of dyspareunia. J Sex Med 8:666–674
Laan E, Everaerd W (1995) Determinants of female sexual arousal: psychophysiological theory and data. Annu Rev Sex Res 6:32–76
Laan E, Everaerd W (1998) Physiological measures of vaginal vasocongestion. Int J Impot Res 10(Suppl 2):S107–S110
Laan E, Rellini AH, Barnes T (2013) Standard operating procedures for female orgasmic disorder: consensus of the International Society for Sexual Medicine. J Sex Med 10:74–82
Labrie F, Archer D, Bouchard C et al (2009) Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 16:923–931
Labrie F, Archer D, Bouchard C et al (2010) High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecol Endocrinol 26:524–532
Lahaie MA, Boyer SC, Amsel R et al (2010) Vaginismus: a review of the literature on the classification/diagnosis, etiology and treatment. Womens Health (Lond Engl) 6:705–719
Lamont JA (1978) Vaginismus. Am J Obstet Gynecol 131:633–636
Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States. Prevalence and predictors. JAMA 281:537–544
Laumann EO, Nicolosi A, Glasser DB et al (2005) Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17:39–57
Leddy LS, Yang CC, Stuckey BG et al (2012) Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. J Sex Med 9:2693–2697
Leiblum SR, Koochaki PE, Rodenberg CA et al (2006) Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause 13:46–56
Leonard LM, Follette VM (2002) Sexual functioning in women reporting a history of child sexual abuse: review of the empirical literature and clinical implications. Annu Rev Sex Res 13:346–388
Levine SB et al (2008) Phase 2B bremelanotide study in pre- and postmenopausal women with FSAD. Poster presentation at ACOG 56th annual meeting, New Orleans, May 3–7 2008
Lewis RW, Fugl-Meyer KS, Corona G et al (2010) Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 7:1598–1607
Lloyd EA (2005) The case of the female orgasm: bias in the science of evolution. Harvard University Press, Cambridge, MA
Long CY, Liu CM, Hsu SC et al (2006) A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 13:737–743
Mah K, Binik YM (2001) The nature of human orgasm: a critical review of major trends. Clin Psychol Rev 21:823–856
Maserejian NN, Shifren JL, Parish SJ et al (2010) The presentation of hypoactive sexual desire disorder in premenopausal women. J Sex Med 7:3439–3448
Maserejian NN, Shifren J, Parish SJ et al (2012) Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther 38:41–62
Masters WH, Johnson VE (1966) Human sexual response. Little; Brown, Boston
Melnik T, Hawton K, McGuire H (2012) Interventions for vaginismus. Cochrane Database Syst Rev 12:CD001760. doi:10.1002/14651858.CD001760.pub2
Meston CM, Hull E, Levin RJ et al (2004) Disorders of orgasm in women. J Sex Med 1:66–68
Middleton LS, Kuffel SW, Heiman JR (2008) Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women. Arch Sex Behav 37:950–961
Mok K, Juraskova I, Friedlander M (2008) The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast 17:436–440
Mongomery JC, Studd JW (1991) Physiological and sexual aspects of the menopause. Brit J Hosp Med 45:300–302
Moyal-Barracco M, Lynch PJ (2004) 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 49:772–777
Muller MJ, Ruof J, Graf-Morgenstern M et al (2001) Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry 34:91–95
Nachtigall L, Casson P, Lucas J et al (2011) Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecol Endocrinol 27:39–48
Naessen T, Rodriguez-Macias K, Lithell H (2001) Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women. J Clin Endocrinol Metab 86:2757–2762
Nappi RE, Albani F, Santamaria V et al (2010a) Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 67:78–83
Nappi RE, Albani F, Santamaria V et al (2010b) Menopause and sexual desire: the role of testosterone. Menopause Int 16:162–168
Nappi RE, Kingsberg S, Maamari R et al (2013) The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 10(9):2232–2241. doi:10.1111/jsm.12235
Nathorst-Boos J, Wiklund I, Mattsson LA et al (1993) Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 72:656–660
Nobre PJ, Pinto-Gouveia J (2009) Cognitive schemas associated with negative sexual events: a comparison of men and women with and without sexual dysfunction. Arch Sex Behav 38:842–851
Nobre PJ, Pinto-Gouveia J, Gomes FA (2006) Prevalence and comorbidity of sexual dysfunctions in a Portuguese clinical sample. J Sex Marital Ther 32:173–182
North American Menopause Society (2012) The 2012 hormone therapy position statement of: the North American Menopause Society. Menopause 19:257–271
Oberg K, Fugl-Meyer K, Fugl-Meyer AR (2005) On Swedish women’s distressing sexual dysfunction: some concomitant conditions and life satisfaction. J Sex Med 2:169–180
Pacik PT (2011) Vaginismus: review of current concepts and treatment using botox injections, bupivacaine injections, and progressive dilation with the patient under anesthesia. Aesthetic Plast Surg 35:1160–1164
Palacios S (2009) Managing urogenital atrophy. Maturitas 63:315–318
Panay N, Maamari R (2012) Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets. Menopause Int 18:15–19
Panjari M, Davis SR (2007) DHEA therapy for women: effect on sexual function and well-being. Hum Reprod Update 13:239–248
Park K, Goldstein I, Andry C et al (1997) Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 9:27–37
Park K, Tarcan T, Goldstein I et al (2000) Atherosclerosis-induced chronic arterial insufficiency causes clitoral cavernosal fibrosis in the rabbit. Int J Impot Res 12:111–116
Pfaus JG (2009) Pathways of sexual desire. J Sex Med 6:1506–1533
Pfaus JG, Giuliano F, Gelez H (2007) Bremelanotide: an overview of preclinical CNS effects on female sexual function. J Sex Med 4:269–279
Philippsohn S, Hartmann U (2009) Determinants of sexual satisfaction in a sample of German women. J Sex Med 6:1001–1010
Philippsohn S, Kruger TH (2012) Persistent genital arousal disorder: successful treatment with duloxetine and pregabalin in two cases. J Sex Med 9:213–217
Plutzky J (2003) The vascular biology of atherosclerosis. Am J Med 115:55S–61S
Poels S, Bloemers J, van Rooij K et al (2013) Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med 10:810–823
Reissing ED, Binik YM, Khalife S et al (2004) Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav 33:5–17
Rellini A (2008) Review of the empirical evidence for a theoretical model to understand the sexual problems of women with a history of CSA. J Sex Med 5:31–46
Rellini A, Meston C (2007) Sexual function and satisfaction in adults based on the definition of child sexual abuse. J Sex Med 4:1312–1321
Rosen RC, Maserejian NN, Connor MK et al (2012) Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause 19:396–405
Rubio-Aurioles E, Kim ED, Rosen RC et al (2009) Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 6:1314–1323
Salonia A, Nappi RE, Pontillo M et al (2005) Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 47:164–169
Salonia A, Giraldi A, Chivers ML et al (2010) Physiology of women’s sexual function: basic knowledge and new findings. J Sex Med 7:2637–2660
Segraves KB, Segraves RT (1991) Hypoactive sexual desire disorder: prevalence and comorbidity in 906 subjects. J Sex Marital Ther 17:55–58
Segraves RT, Clayton A, Croft H et al (2004) Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 24:339–342
Semmens JP, Semmens EC (1984) Sexual function and the menopause. Clin Obstet Gynecol 27:717–723
Shifren JL (2011) Increasing our understanding of women’s sexuality at midlife and beyond. Menopause 18(11):1149–1151
Shifren JL, Braunstein GD, Simon JA et al (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682–688
Shifren JL, Davis SR, Moreau M et al (2006) Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13:770–779
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB (2008) Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 112:970–978
Shulman LP, Portman DJ, Lee WC et al (2008) A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. J Womens Health (Larchmt) 17:569–578
Sims JS (1861) On vaginismus. Trans Obstet Soc Lond 3:356–367
Sinha A, Ewies AA (2013) Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 16:305–312
Smith WJ, Beadle K, Shuster EJ (2008) The impact of a group psycho-educational appointment on women with sexual dysfunction. Am J Obstet Gynecol 198:697e1–697e6
Stahl SM, Sommer B, Allers KA (2011) Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 8:15–27
Staples J, Rellini AH, Roberts SP (2012) Avoiding experiences: sexual dysfunction in women with a history of sexual abuse in childhood and adolescence. Arch Sex Behav 41:341–350
Suckling J, Lethaby A, Kennedy R (2003) Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003;(4):CD001500
ter Kuile MM, Both S, van Lankveld JJ (2010) Cognitive behavioral therapy for sexual dysfunctions in women. Psychiatr Clin North Am 33:595–610
Thorp J, Simon J, Dattani D et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 9:793–804
Tkachenko N et al (2013) An open−label, single and multiple−application of intranasal testosterone gel (tbs−2) in healthy pre−menopausal female subjects at three dose levels. Annual meeting ISSWSH: New Orleans, USA
Traish AM, Botchevar E, Kim NN (2010) Biochemical factors modulating female genital sexual arousal physiology. J Sex Med 7:2925–2946
Triggle CR, Hollenberg M, Anderson TJ et al (2003) The endothelium in health and disease—a target for therapeutic intervention. J Smooth Muscle Res 39:249–267
Trudel G, Marchand A, Ravart M et al (2001) The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Relat Ther 16:145–164
U.S. Department of Health and Human Services, Food and Drug Administration (2000) Guidance for industry. Female sexual dysfunction: clinical development of drug products for treatment. Draft guidance. In: Center for Drug Evaluation, Research (CDER) (eds)
Ückert S, Kuczyk MA, Oelke M (2013) Phosphodiesterase inhibitors in clinical urology. Expert Rev Clin Pharmacol 6:323–332
Van den Hout M, Barlow D (2000) Attention, arousal and expectancies in anxiety and sexual disorders. J Affect Disord 61:241–256
van Lankveld JJ, Granot M, Weijmar Schultz WC et al (2010) Women’s sexual pain disorders. J Sex Med 7:615–631
Waldinger MD, Schweitzer DH (2009) Persistent genital arousal disorder in 18 Dutch women: Part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med 6:482–497
Waldinger MD, van Gils AP, Ottervanger HP et al (2009a) Persistent genital arousal disorder in 18 Dutch women: Part I. MRI, EEG, and transvaginal ultrasonography investigations. J Sex Med 6:474–481
Waldinger MD, Venema PL, van Gils AP et al (2009b) New insights into restless genital syndrome: static mechanical hyperesthesia and neuropathy of the nervus dorsalis clitoridis. J Sex Med 6:2778–2787
West SL, D’Aloisio AA, Agans RP et al (2008) Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 168:1441–1449
Wiedeking C, Ziegler MG, Lake CR (1979) Plasma noradrenaline and dopamine beta-hydroxylase during human sexual activity. J Psychiatr Res 15:139–145
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Salonia, A., Castagna, G., Montorsi, F. (2015). Female Sexual Dysfunction (FSD). In: Mirone, V. (eds) Clinical Uro-Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45018-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-45018-5_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45017-8
Online ISBN: 978-3-662-45018-5
eBook Packages: MedicineMedicine (R0)